Significant Insider Buying Registered in Holdings of VHT

Insider buying activity has been notable within the Vanguard Health Care ETF (VHT), with 22.6% of its weighted holdings experiencing such purchases in the past six months. Specifically, Elevance Health Inc (ELV), a 1.44% holding in VHT, saw two directors/officers acquire shares totaling over $2.8 million, while Masimo Corp. (MASI), a 0.13% holding, also reported two directors/officers buying shares worth over $460,000. This widespread insider confidence across key components of the ETF suggests a positive outlook from company leadership for these healthcare sector constituents.

Analysis

The Vanguard Health Care ETF (VHT) exhibits notable insider confidence, with 22.6% of its weighted underlying holdings experiencing insider buying within the past six months. This broad-based activity suggests a positive internal outlook across a significant portion of the healthcare sector components within the ETF. Such consistent insider purchases often signal management's belief in future performance or current undervaluation.

Elevance Health Inc (ELV), which constitutes 1.44% of VHT's assets and is its 18th largest holding, saw substantial insider investment. Two directors and officers, including President and CEO Gail Boudreaux, collectively purchased over $2.8 million worth of shares in July and August 2025. These significant investments, particularly from top executives, indicate strong conviction in ELV's operational and financial prospects.

Similarly, Masimo Corp. (MASI), a 0.13% holding within VHT, recorded two director purchases totaling over $468,000 in August 2025. While a smaller component of the ETF, the insider activity in both ELV and MASI, coupled with the overall trend across VHT's portfolio, reinforces a moderately positive sentiment for these underlying companies. This pattern of insider buying across multiple constituents points to potential fundamental strength within the healthcare segment.

Key Decisions for Investors

• Investors should consider the widespread insider buying within VHT's weighted holdings as a positive signal for underlying company fundamentals and potential future performance.
• A deeper dive into Elevance Health (ELV) and Masimo Corp. (MASI) is warranted, given the substantial insider purchases by key executives and directors, which may indicate undervaluation or strong growth prospects.
• The observed insider confidence across multiple VHT components suggests a potentially favorable environment for the broader healthcare sector, prompting a review of current sector allocations.